Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

January 31, 2017

Conditions
HypertensionVascular DiseasesCardiovascular Diseases
Interventions
DEVICE

Renal Denervation using the Symplicity Renal Denervation System

Subjects randomized to the renal denervation group underwent angiography and renal denervation.

OTHER

Sham Renal Denervation

Prior to enrollment closure, subjects were treated with sham renal denervation. After enrollment closure, subjects previously enrolled were no longer eligible to cross-over.

DEVICE

Renal Angiography

Subjects who met all criteria after the screening period did undergo a renal artery angiogram to evaluate renal artery anatomy. Only subjects with eligible renal artery anatomy were randomized.

Trial Locations (3)

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

30309

Piedmont Hospital, Atlanta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT01972139 - Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4 | Biotech Hunter | Biotech Hunter